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Objectives: The aim of this study was to conduct a discrete choice experiment with patients affected 
by colorectal cancer to understand their preferences for different attributes of the chemotherapy 
supply. Our overall goal is to provide evidence on the relative importance of each attribute in order 
to tailor chemotherapy supply according to patients' priorities in the design or reorganization 
processes of cancer services. 
Methods: Focus groups were used to identify the attributes and levels for the discrete choice 
experiment. The attributes were: continuity of care, understanding, information, treatment choice, 
and time for therapy. Respondents were asked to choose between two mutually exclusive hypothetical 
alternatives of chemotherapy supply. Patients completed the discrete choice experiment along with 
health-related quality of life and patients’ satisfaction questions. Conditional and mixed logistic 
models were used to analyses the data. 
Results: Patients with colorectal cancer treated with chemotherapy (n=76) completed the survey. The 
most important aspects of chemotherapy supply were: “Providing detailed and complete information” 
and “High ability in understanding” patients. Preferences were also influenced by the availability of 
a trusted doctor. Except for one attribute (waiting time for therapy), all other characteristics 
significantly influenced respondents’ preferences. 
Conclusions: Results should support a policy of strengthening medical doctors’ capabilities to 
communicate with patients, providing them complete information and involving them in the clinical 
decisions. Specifically, the findings should be used to improve current provision of cancer care by 
identifying areas of preferred intervention from the perspectives of patients in order to tailor the 
service supply accordingly.  
Keywords: patient satisfaction; chemotherapy; discrete choice experiment; patient preferences.  
Short title: Patients' preferences on outpatient chemotherapy. 
Introduction 
In cancer care, although the outcomes of treatment are very important to patients, recent years have 
seen a growing interest in patient satisfaction [1]. Dissatisfaction with care can compromise 
compliance with beneficial treatment recommendations, and thereby undermine therapeutic 
effectiveness, prognosis and outcomes [2-4].  
Given the relevance of patient-centred care as a quality dimension, its monitoring should be ensured 
by specific measurement systems, in line with the provisions for effectiveness, efficiency and safety. 
In cancer treatment centres, patients should routinely be surveyed with respect to several relevant 
domains, such as physical comfort, emotional support, enabling informed decision-making, respect 
for patients’ preferences and values, involvement of family and friends and continuity of care [5]. 
When the objective is to study or understand predictors of patient satisfaction regarding the service 
experienced, diverse methodologies are available, including self-reported questionnaires, in-depth 
interviews, focus-group discussions and analyses of patient feedback and concerns. Results can be 
used by healthcare providers to understand weaknesses in the delivery process, in order to design and 
track quality improvement.  
Stated-preference methods, such as discrete choice experiments (DCEs), provide a means to elicit 
information about which features of healthcare systems patients would value most highly if they had 
the opportunity to choose [6-9]. The evidence produced can provide information on patients’ 
expectations and can contribute to the design of new healthcare delivery systems or to improving 
current ones, using a patient-centred approach. 
In the DCE framework, a good or service can be described by a set of characteristics, also known as 
attributes, which are in turn scaled at different levels. DCEs are typically carried out in studies that 
consist of a series of choice tasks. A choice task consists of two or more realistic but hypothetical 
options, (i.e., “choice sets” in DCE nomenclature), from which patients are invited to choose. In 
DCEs, respondents must choose between two or more options that are characterized by varying levels 
of the options’ relevant features, (i.e., attributes). The choice of attributes is a key issue in DCEs. The 
literature suggests involving the main stakeholders through interviews or focus groups, to identify the 
aspects that will be used to describe the service [6, 10]. Respondents are expected to make a trade-
off between attributes, under the assumption that individuals choose the alternative that maximizes 
their utility. Patients’ preferences are derived through the estimation of the weights that respondents 
place on each attribute defining the cancer care service. 
In cancer care, in recent years, DCEs have been widely used to investigate patient preferences, mainly 
with regard to treatments [11-16] and screening programmes [17, 18], with most of the studies related 
to colorectal screening [17, 19-23]. Studies conducted to determine patients’ preferences in cancer 
care management are less common [24-28]. 
In 2000, Piedmont Region established a regional cancer network (RCCN), with the aim of 
guaranteeing homogeneous and uniform care over the whole region and supporting patients in every 
phase of the disease, using a patient-centred approach (http://www.reteoncologica.it/). For this 
purpose, two organizational bodies were created: the “Service and Reception Centre”, for the first 
reception of the patient and for offering support during the patterns of care and the “Interdisciplinary 
Care Group”, where different specialists discuss the case and plan the therapeutic approach together. 
The extent to which the patient-centred organization of the RCCN is really meeting patient 
preferences has not yet been assessed. 
Using a discrete choice experiment (DCE), the aim of the present study was to estimate patient 
preferences for different attributes of the chemotherapy supply in a sample of colorectal cancer 
patients at the largest referral centre of the RCCN. Preference heterogeneity between patients and the 
impact on preferences of satisfaction regarding the service previously experienced, were also 
assessed.  
Our overall goal is to provide evidence on the relative importance of each attribute, in order to tailor 




The present study was nested within a prospective study aimed at evaluating changes in quality of 
life in colorectal cancer patients, between diagnosis and six-month follow-up. Respondents were 
enrolled at the cancer care unit of the “Città della Salute e della Scienza” hospital of Turin, between 
October 2014 and October 2016. Inclusion criteria were a new diagnosis of CRC and patient ages 
greater than 18 years. Patients with previous neoplasm, cognitive disorders (clinical judgement) or 
insufficient understanding of the Italian language were excluded. In this prospective study, patients 
were enrolled during the first multidisciplinary visit to decide chemotherapy treatment and were re-
evaluated at the six-month follow-up visit (between April 2015 and April 2017). At baseline 
respondents completed demographic and self-reported health status and mood disorders 
questionnaires. At the follow-up visit, in addition to the previous questionnaires, they also filled out 
a questionnaire assessing satisfaction with the service experienced. Moreover, the DCE was offered 
to a subsample of all the patients receiving chemotherapy who were willing to participate in the 
experiment. They were then presented with information about the DCE tasks, including the attributes 
used, and instructed to imagine the cancer care service that they could have experienced. A member 
of the research team was available to help in filling out the questionnaire. All analyses reported in the 
present paper refer to the six-month follow-up visit. The study was conducted in strict accordance 
with the ethical guidelines in the Declaration of Helsinki and was approved by the Human Research 
Ethics Committee at “Città della Salute e della Scienza” hospital (registration number 0077310). All 
participants were informed about the study and consented to participation. They were assured that 
participation was voluntary. Participants were also assured that refusal to participate would not affect 
their care.  
 
Discrete Choice Experiment 
To establish the most relevant attributes of an oncology service, we used the results of four focus 
groups involving the main “stakeholders”, two with cancer patients and caregivers and two with 
professionals (doctors and nurses), lasting about two hours each. Twelve patients were recruited from 
the outpatient service of the cancer care unit, using the method of purposive sampling, which aims to 
obtain maximum variation in patient characteristics [29], including age and cancer sites (breast, 
colorectal or haematological cancers). Five paired caregivers also participated. Focus groups for 
professionals included 12 voluntary participants with different specializations (breast, colorectal or 
haematological cancers). Focus groups were conducted by two researchers with experience with 
healthcare service patients: a skilled moderator who helped participants to identify the core attributes 
of the chemotherapy service delivery and an observer who concentrated on group dynamics and noted 
the discussion. The focus groups were conducted in three steps, directly recording contributions with 
written notes. First, the aim of the study was presented, and participants were invited to focus on their 
personal experience with the cancer care service. Second, two brainstorming conversations took 
place, where each participant spontaneously indicated: 1) the most relevant aspects of the cancer care 
service (attributes) for him or her and 2) the list of levels for each aspect. In the third step, the 
attributes and levels identified were synthetized for patients. Five key attributes likely to influence 
the patient’s satisfaction were identified: continuity of care, understanding, information, treatment 
choice and time for therapy. These attributes were scaled at two or three levels, as reported in Table 
1. 
The DCE consisted of several choice sets (scenarios), each containing two mutually exclusive 
hypothetical alternatives for chemotherapy supply. Alternatives were characterized by different levels 
of a set of attributes. The DCE response format used was the “pick-one” option. For each scenario, 
respondents were asked which hypothetical chemotherapy service was, in their opinion, preferable. 
In line with the main objective of the study, to investigate single aspects of the cancer care service 
with respect to patient satisfaction, the DCE was of an unlabelled type [30], with generic titles for the 
alternatives (service “A” or “B” in Figure 1).  
To construct the choice sets (scenarios), experimental designs were used, so that the attributes were 
uncorrelated and therefore yielded unconfounded estimates of the parameters. The combination of 
attributes and levels in the study resulted in (33*22) = 108 possible alternatives. A full fractional 
design, incorporating all possible scenarios, could enable all interaction effects to be investigated. 
However, this is not feasible, particularly for older patients with cancer, who are unlikely to be able 
to handle a large number of choice sets. To provide a manageable task for respondents, the D-
optimality criterion was used to maximize the efficiency of the design [30]. Eighteen choice sets with 
two alternatives, (i.e., hypothetical cancer services), were constructed. To make the questionnaire 
more manageable for patients, the choice sets were split into two blocks of nine, and half the 
respondents were randomly assigned to each block. Each patient was required to complete one block. 
The scenarios were randomized to prevent order effects bias. One additional control scenario, with 
the best (favourite) level of all attributes, was used as a validity test. The additional scenario was 
excluded from the analyses.  
On the basis of the rule of thumb proposed by Johnson and Orme [31], the sample size (N) required 
to estimate the main effects of the attributes should be N > 500c /(t x a), where t is the number of 
choice sets, a is the number of choices per task and c is the largest number of levels for any one 
attribute. With 18 choice sets (t = 18), five attributes scaled by three levels (c = 3) and two alternatives 
(a = 2), a sample size of 42 was required. This sample size is in line with the DCE literature, 
suggesting that the minimum number of participants per block should be 20, i.e., a minimum sample 
size of 40 participants for a two-block design [10].  
 
Questionnaires  
Before performing the DCE, respondents filled out the Italian validated version of the following 
questionnaires: the Hospital Anxiety and Depression Scale (HADS) for measuring emotional 
disorders, the EORTC IN-PATSAT32 questionnaire for estimating satisfaction with the service 
received during their previous treatment and the EORTC QLQ-C30 questionnaire on quality of life.  
The HADS is a screening tool comprising 14 multiple-choice items (0-3 score range for each), seven 
items probing symptoms of anxiety and seven probing symptoms of depression. HADS anxiety and 
depression scores can range from 0 to 21 (most severe symptoms) [32, 33].  
The EORTC IN-PATSAT32 is a 32-item questionnaire organized into 11 multi-item scales and three 
single items. The subscales are measures of: doctors’ and nurses’ technical skills, (e.g., knowledge, 
experience, assessment of physical symptoms), interpersonal skills, (e.g., interest, willingness to 
listen) information provision (about the disease, medical tests and treatment) and availability, (e.g., 
time devoted to the patient), together with satisfaction with other hospital staff (receptionists, 
laboratory assistants, technicians), interpersonal skills and information provision, exchange of 
information within the care team, waiting time, hospital access, hospital comfort and overall 
satisfaction with care. The IN-PATSAT32 scales range from 0 to 100, with higher scores reflecting 
a higher level of satisfaction [34]. 
The EORTC quality-of-life questionnaire (QLQ-C30) [35] is composed of 30 items that define six 
functional dimensions (emotional, physical, global health, cognitive, role and social), eight symptoms 
(appetite loss, constipation, fatigue, nausea/vomiting, pain, diarrhoea, dyspnoea and insomnia) and 
one item related to financial problems. These dimension scores range from 0 to 100. For functional 
dimensions, a higher score represents a higher level of QoL, while for the symptoms scale lower 
values indicate a better QoL.  
Additional data collected included the patient’s age, gender, educational level, marital status, type of 
cancer (colon/rectum) and TNM cancer stage, classified as early stage (I or II) versus advanced stage 
(III or IV). 
 
Data Analysis 
Respondents’ characteristics were described as means and frequencies. The IN-PATSAT32 
satisfaction subscale and the QLQ-C30 quality-of-life functional subscale, were synthetized as means 
and standard deviations, while the QLQ-C30 symptoms were presented as percentages, due to their 
low frequencies. HADS anxiety and depression scales were presented both as means and standard 
deviations and as a percentage of respondents with a pathological or borderline score (HADS score 
> 8). Non-responders’ characteristics were analysed to assess possible selection bias. Patients’ 
characteristics were also analysed stratifying by stage of disease and cancer site. 
Data from the DCE were analysed within the framework of random utility theory, which assumes that 
respondents choose the alternative that maximizes their utility. A conditional logistic regression 
model was initially used, assuming a homogeneous preference among all respondents. In order to 
investigate the potential existence of preference heterogeneity, a mixed logistic regression model was 
also considered. The Bayesian Information Criterion (BIC) and McFadden’s pseudo R-squared (R2) 
were used to compare the conditional and mixed logit models. As a rule of thumb, well-fitted models 
occur with a pseudo R2 greater than 0.30 [30]. Attribute levels were included in the analysis as dummy 
variables.  
The conditional logit regression model was also stratified according to the median value of the general 
satisfaction, as measured by the IN-PATSAT32 scale. The general satisfaction dichotomous variable 
was also included in the model as interacting with the attributes. 
DCE analyses were performed using the statistical software package NLOGIT version 4.0 [36], and 




The prospective study enrolled 258 colorectal cancer patients. One hundred and forty-two underwent 
chemotherapy and were invited to complete the DCE survey during the six-month follow-up visit. 
The actual number of respondents was 76, mainly due to complexity of the DCE. One patient was 
excluded from the analysis after failing the additional control scenario test. No statistical differences 
were found between respondents and non-respondents, for demographic data and IN-PATSAT32 
subscales (appendix 1, table A1). 
Table 2 summarizes the demographic and clinical characteristics of the 75 respondents. Fifty percent 
of the respondents were males (n = 39) with a mean age of 61.6 years (s.d. = 10.6). Sixty-four percent 
of respondents lived with a partner. The majority had a diagnosis of colon cancer (64%), and about 
20% had stage I-II disease.  
Anxiety and depression scores were on average low, with only 16% and 12% of patients with 
borderline or pathological anxiety and depression respectively (scores > 8). 
The sample reported high QoL scores (mean value exceeding 80) on almost all functional scales, 
except for the global health scale, with an average score of 67. The overall good health status of these 
patients was also evidenced by the low prevalence of almost all symptoms, except fatigue, which was 
present in 81% of cases.  
Results from the IN-PATSAT32 questionnaire are shown in Figure 2. Mean satisfaction scores for 
doctors ranged from 72.3 (doctor availability) to 75.7 (doctors’ technical skills). Mean satisfaction 
scores for nurses ranged from 70.1 (nurse information) to 78.8 (nurses’ technical skills). The lowest 
mean score was 58.8, which related to hospital access. Overall, the mean general satisfaction score 
was 75.7. Neither the patients’ characteristics nor any of the measured scales were associated with 
the cancer site or stage (appendix 1, table A2 and A3).  
 
Results of DCE Experiment 
The conditional logit estimates for the study sample are reported in Table 3. All attributes had a 
positive coefficient sign as expected, having fixed the worst option as the reference category. For 
example, the “information” attribute has a positive value indicating that utility increases in the 
presence of a doctor providing information (generic or detailed) about the disease and treatments. 
Moreover, the sizes of coefficients also indicate that they were logically ordered (higher impact on 
utility for detailed and complete information). Except for one attribute (time for therapy), all other 
cancer care services characteristics considered in this study significantly influenced respondents’ 
preferences. “Providing detailed and complete information” and “High ability to understand” were 
the most important attributes. Table 4 reports random logit estimates investigating the potential for 
preference heterogeneity in respondents. Nevertheless, using a mixed logit model improved the model 
fitting compared to the conditional logit model, as evidenced by the BIC statistics, (i.e., lower is 
better) and McFadden’s pseudo R2, (i.e., higher is better). Ranking of preferences was similar in both 
models, but taking into account patient heterogeneity, all cancer care service attributes were 
statistically significant (p < 0.01). Coefficients for standard deviations suggest a relevant 
heterogeneity among respondents, particularly in the assessment of “treatment choice” and 
“understanding”.  
A subgroup analysis was undertaken, stratifying the whole sample by general satisfaction score 
(lower/upper median score of 75). Results are reported in Table 5. Overall, no relevant differences 
were observed. In the subsample of respondents with lower general satisfaction scores (≤ 75), the 
sign and significance of the attributes remained unchanged. For those with high general satisfaction, 
“continuity of care” and “time for therapy” became not statistically significant. When the general 
satisfaction dichotomous variable was also included in the main model as interacting with the 
attributes, only “time for therapy”, as an interaction term, was significant.  
 
Discussion 
The aim of this study was to explore patients’ preferences regarding chemotherapy supply in a cohort 
of colorectal cancer patients at the cancer care unit of a referral centre of the RCCN. Since the RCCN 
has a strong commitment to guarantee a patient-centred approach, the need for robust evidence on 
patients’ preferences has been identified as a research priority, for better tailoring of the 
organizational strategies. This study provides evidence, supported by quantitative methods, on the 
relative importance of each attribute in order to tailor chemotherapy supply according to patients’ 
priorities. Results can be used in the design or re-organization processes of cancer services. 
DCE analysis has been identified as the proper approach to provide a measure of the preferences of 
patients towards relevant dimensions of cancer care services, and to assess the presence of 
heterogeneity among patients [38]. This approach has not generally been used in the context of cancer 
services management, apart from in screening programmes, but it has the potential to be strongly 
informative. The study has also the objective of understanding the potential of using this approach in 
cancer care management, in order to make the decision process more transparent and explicit [39]. 
Specifically, in the context of shared decision-making as a means of engaging patients in their health 
care choices, the findings of this study should be used to improve current provision of cancer care by 
identifying areas of preferred intervention from the perspectives of patients, in order to tailor the 
service supply accordingly. As highlighted by patient-centred care and shared decision-making 
approaches, if the patient’s core values and goals are taken into account, the clinicians are facilitated 
in supporting patients with their healthcare choices. Shared decision-making results in lower 
utilization of healthcare resources, creates more patient autonomy and improves patient outcomes 
[40-43].  
The attributes of the service that have been found to be most preferred by patients were those related 
to the doctor’s interpersonal skills, specifically understanding, ability to provide information about 
the disease, therapies and prognosis and ability to involve patients in the decision-making process 
regarding their care. Results on interpersonal skills are in line with the literature, where 
understanding, empathy and relational versatility have been identified as relevant [44, 45]. Desire for 
substantial engagement in decision-making has previously been demonstrated among breast cancer 
patients [46, 47]. Furthermore, Schmidt and colleagues [2016], observed that preferences were not 
homogenous among lung cancer patients, and some subjects seemed to prefer a passive rather than 
an active role in decision-making [48]. The present study has shown a greater preference in patients 
for being involved in the decision-making process rather than choosing their own treatment after 
consulting the doctor, as already reported in the literature for colorectal cancer [49]. 
The least relevant factor was the waiting time for obtaining the therapy, suggesting a relatively minor 
role for patients’ preferences regarding tangible organizational aspects, compared with interpersonal, 
emotional and supportive ones. Since in the IN-PATSAT32 questionnaire, patients reported scores 
for hospital access that were lower than those related to doctors’ and nurses’ interpersonal skills, we 
could expect to observe higher preferences for tangible organizational aspects from DCE also. 
However, doctors’ and nurses’ interpersonal skills scored higher. As observed by Petrosyan [2017], 
the results of questionnaires on patient satisfaction must always be evaluated with caution: high 
satisfaction scores may not necessarily reflect excellent service, but merely a reluctance to criticize 
and the social unacceptability of complaining [50]. Nevertheless, preferences originating from the 
DCEs reflect the individual priority rankings of respondents. Indeed, in the results of our stratified 
analysis, preferences were not even affected by the general satisfaction measured by the IN-
PATSAT32 instrument. 
To the best of our knowledge, this is the first Italian DCE to study preferences with respect to cancer 
care services and should help to inform reorganization of clinical practice supply in this context. 
Within the RCCN, these results should support a policy of strengthening medical doctors’ abilities to 
communicate with patients, to provide complete information and to involve patients in clinical 
decisions. This objective could be achieved, for instance, with specific training on improving 
relational skills and increasing the time dedicated to dialogues with patients.   
Attributes were identified through focus groups with patients, caregivers and professionals, with a 
strong linkage with the local context, according to literature suggestions regarding patient-centred 
care [51]. It is thought that, since the attributes investigated are not context specific, the present 
conclusions are likely to be generalizable to the organization of chemotherapy services within the 
National Healthcare Service (Italian Servizio Sanitario Nazionale), in various organizational contexts 
and for different types of cancers.   
As well as the practical and specific suggestions arising from the results, the study is important as a 
first attempt to provide a new kind of approach, suitable for application to other phases of the pattern 
of care, various organizational contexts and other types of cancer. 
A general limitation of the study is the low sample size that prevented in-depth investigation of the 
heterogeneity of preferences among patients. Although the number of patients participating in the 
DCE (N = 75) was greater than that required by the sample size calculation for principal effect 
detection (N = 48), it was not large enough for interactions analysis. Unfortunately, the exclusion 
criteria did not allow the number of subjects to be increased sufficiently in the DCE, considering the 
average age of colorectal cancer patients and the presence of cognitive impairment. 
Another limitation of the study that must be acknowledged is the sample heterogeneity, due to the 
inclusion of both colon and rectum cancers, at all stages, with every possible pattern of care besides 
chemotherapy. Restricted inclusion criteria would have improved the homogeneity of the sample but 
would have reduced the study sample size and its generalizability. As colon and rectum cancers, 
independently of the stage, share the same outpatient cancer care organization in RCCN (the same 
physical spaces and equipment), heterogeneity due to the cancer site or stage is not likely to strongly 
affect preferences. No relevant differences in self-reported patient satisfaction and quality of life were 
identified in association with cancer site and stage. Therefore, preferences for cancer service attributes 
should not vary.   
 
Finally, these results should be discussed with decision-makers on the one hand, and professionals 
on the other, in order to understand how to translate information on patient preferences into 
organizational and behavioural changes in cancer care.  
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Attributes        
  Coefficients  SE  Coefficients  SE 
Continuity of care        
No (reference)        
Yes 7.44  (1.58)**  1.41  (1.29) 
Understanding         
Low ability (reference)        
High ability 15.09  (2.89)**  10.65  (2.16)** 
Information         
Not complete (reference)        
Generic 4.55  (1.42)**  5.36  (1.40)** 
Detailed and complete  16.95  (3.19)**  5.36  1.40)** 
Treatment choice         
The physician alone (reference)        
The patient after consulting the physician 3.07  (1.50)*  15.67  (3.15)** 
The physician and the patient together  11.67  (2.57)**  15.66  (3.15)** 
Time for therapy         
More than 5 hours (reference)        
Around 4‐5 hours 3.92  (1.72)*  10.16  (2.58)** 
Less than 4 hours 6.8  (1.90)*  7.06  (1.84)** 
       
Log‐likelihood function  ‐312.6363       
Info. criterion: BIC  1.06145       
McFadden’s pseudo R‐squared  0.332       
No. of respondents  75       
No. of observations  1,350       
 





















         
Attributes         
  Coefficients  SE  Coefficients  SE 
Continuity of care        
No (reference)        
Yes 0.59  (0.19)**  0.54  (0.22) 
Interpersonal skills         
Low ability (reference)        
High ability 1.13  (0.22)**  0.90  (0.17)** 
Information         
Not complete (reference)        
Generic 0.35  (0.21)  0.25  (0.28) 
Detailed and complete  1.34  (0.20)**  1.02  (0.25)** 
Treatment choice         
The physician alone (reference)        
The patient after consulting the physician 0.32  (0.23)  0.33  (0.21) 
The physician and the patient together  0.94  (0.25)**  0.73  (0.27)** 
Time for therapy         
More than 5 hours (reference)        
Around 4‐5 hours 0.45  (0.20)*   ‐0.12  (0.26) 
Less than 4 hours 0.64  (0.17)**  ‐0.07  (0.28) 
       
Log‐likelihood function    ‐195.13    ‐123.75   
Info. criterion: BIC    0.995    1.244   
McFadden’s pseudo R‐squared    0.358    0.230   
No. of respondents    49    26   








































































































technical skills 75.0  (20.7)  75.8  (19.3) 
interpersonal skills 77.6      (22.7)     72.8      (23.2) 
information provision 76.9  (22.6)  74.3  (23.8) 
availability 76.0  (23.6)  71.6  (24.1) 
IN‐PATSAT32 nurses’scales, mean years (SD)     
technical skills 75.6  (18.5)  78.1  (18.2) 
interpersonal skills 76.3  (18.3)  79.3  (19.2) 
information provision 73.7  (26.1)  69.3  (25.1) 
availability 75.0  (22.8)  77.0  (21.4) 
IN‐PATSAT32 hospital scales, mean years (SD)     
Other hospital staff interpersonal skills 69.2  (26.9)  69.4  (21.4) 
Waiting time 71.2  (28.6)  69.4  (22.5) 
Hospital access 46.2  (25.2)  61.5  (25.6) 
Exchange information 75.0  (22.8)  70.2  (23.9) 
Hospital comfort  75.0  (22.8)  69.8  (20.8) 













technical skills 73.7  (19.4)  77.1  (19.5) 
interpersonal skills 74.2  (21.4)  73.3  (24.3) 
information provision 77.2  (22.1)  73.1  (24.4) 
availability 72.2  (21.1)  72.4  (25.9) 
IN‐PATSAT32 nurses’scales, mean years (SD)     
technical skills 75.0  (17.5)  79.5  (18.6) 
interpersonal skills 78.0  (16.3)  79.4  (20.8) 
information provision 68.9  (19.9)  70.8  (28.5) 
availability 74.7  (22.2)  78.1  (21.1) 
IN‐PATSAT32 hospital scales, mean years (SD)     
Other hospital staff interpersonal skills 67.2  (20.2)  70.8  (23.7) 
Waiting time* 61.7  (23.0)  75.3  (22.3) 
Hospital access 54.8  (27.5)  61.6  (24.9) 
Exchange information 69.4  (20.1)  72.2  (26.0) 
Hospital comfort  66.9  (20.8)  73.3  (21.2) 
General satisfaction 71.8  (20.2)  78.4  (20.6) 
SD Standard Deviation;  
* indicates differences statistically significant at p value<0.05 (Wilcoxon test for continuous variable; Fisher 
exact test for categorical variable) 
 
  
 
 
